🚨 Emergency Pod 🚨 Chinese Peptides Made the NYT, with Sina Hartung

So it really is a new year, new me, because I made The New York Times for my commentary on unregulated Chinese peptides. My dear friend Sina joins me to break down the article and give serious, nuanced takes on peptides and wellness risk profiles. We also touch on the Nicholas Maduro kidnapping and how we each monitored the situation. MOTS will always be here in the event of emergencies, because the timeline never sleeps.

Watch on X; listen on Apple Podcasts or Spotify.

Sponsors

• Inference trains and deploys custom language models for some of the fastest growing companies in history. If you're spending more than $50,000/month on OpenAI, Anthropic, or Gemini, they can help you save money, improve quality, and ultimately make your business more efficient.
• Lighthouse makes U.S. work and green-card visas easy for technical talent and fast-growing teams. From free evaluation to streamlined onboarding, personalized support and full document prep they get your top engineers, researchers and founders through the visa journey in weeks not months. Trusted by startup builders who don’t want immigration to be a blocker.
• Trufflepig is the AI-native spreadsheet software that allows you to work at the speed of thought and they’re hiring. Join a fast-growing AI startup building something that people will actually use.
• Morph is the better way to apply AI code edits. Merge LLM changes into your code and files - at 10,500+ tokens per second. 98% accurate + 2x faster than search-and-replace.

Chapters

• 0:00 intro
• 1:31 monitoring the situation
• 3:50 MOTS made the NYT
• 7:51 my peptide skepticism
• 8:45 @SinaHartung endocrinology background + risk tolerance
• 10:46 clarifying my position
• 17:35 headshot
• 18:12 people assessing risk
• 22:33 @Bonecondor peptide rave